加载中
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
常规交易时段
US$21.87
−US$0.21 · -0.95%
盘中时间采用ET。市场数据可能有所延迟。
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
日内区间
当前US$21.87
52周区间
当前US$21.87
盘中时间采用ET。市场数据可能有所延迟。
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
日内区间
当前US$21.87
52周区间
当前US$21.87
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 2.36亿 USD | 2.05亿 USD | 1.49亿 USD | 1.22亿 USD | 9804.9万 USD |
| 销货成本 | 6368.7万 USD | 5612.9万 USD | 3747.9万 USD | 3162.9万 USD | 2464.6万 USD |
| 毛利 | 1.73亿 USD | 1.49亿 USD | 1.11亿 USD | 9066万 USD | 7340.3万 USD |
| 研究与开发 | 910.2万 USD | 1103.4万 USD | 1089.5万 USD | 845.2万 USD | 554.3万 USD |
| 销售、一般及管理费用 | 1.93亿 USD | 1.67亿 USD | 1.26亿 USD | 1.04亿 USD | 8573.4万 USD |
| 营业费用 | 2.02亿 USD | 1.78亿 USD | 1.38亿 USD | 1.16亿 USD | 9142.7万 USD |
| 利息收入 | — | — | 19.8万 USD | — | — |
| 利息支出 | 599.6万 USD | 262.1万 USD | — | 242.4万 USD | 224.7万 USD |
| 折旧和摊销 | 2111.9万 USD | 1908万 USD | 1738.5万 USD | 1309.9万 USD | 1068万 USD |
| 营业利润 | −2899.9万 USD | −2952.1万 USD | −2675.1万 USD | −2539.9万 USD | −1802.4万 USD |
| 净利润 | −3964.8万 USD | −3782.2万 USD | −2097.4万 USD | 125.8万 USD | −1626万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$25.25
上涨空间 15.45%报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1245.45万0.00%2.3万亿 USD0.03%US$380.81-0.20%
iShares Russell 2000 ETFIWM1001.15万0.01%787.4亿 USD0.19%US$276.14-0.63%
Vanguard Extended Market ETFVXF466.82万0.00%954亿 USD0.05%US$231.76-0.75%
Dimensional - US Small Cap ETFDFAS320.83万0.01%338.04亿 USD0.31%US$77.91-0.33%
iShares Russell 2000 Value ETFIWN272.03万0.02%137.49亿 USD0.24%US$210.41-0.32%
Vanguard Russell 2000 ETFVTWO236.64万0.01%180亿 USD0.06%US$111.53-0.66%
Schwab U.S. Small-Cap ETFSCHA201.46万0.01%217.13亿 USD0.03%US$32.465-0.60%
Dimensional - US Core Equity 2 ETFDFAC169.71万0.00%885.59亿 USD0.21%US$45.255-0.12%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFDimensional - US Small Cap ETFDFASiShares Russell 2000 Value ETFIWNVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHADimensional - US Core Equity 2 ETFDFACAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
